Publications 2005
1 Death in the era of potent antiretroviral therapy: shifting causes, new challenges. M Zwahlen and JD Lundgren
Int J Epidemiol. 2005 Jan 13. abstract
2 Risk of AIDS and death at given HIV-RNA and CD4 count levels, according to specific antiretroviral drugs in the regimen. Holkmann Olsen C, Gatell J, Ledergerber B, Katlama C, Friis-Møller N, Weber J, Horban A, Staszewski S, Lundgren J, Phillips A.
AIDS. 2005 Feb 18; 19:319-330 abstract
3 Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis-Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, Kok-Jensen A, Andersen P, Weldingh K.
Clin Diagn Lab Immunol. 2005 Apr, 12(4):491-6 abstract
4 Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort. D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, K Zilmer, S Vella, O Kirk, and JD Lundgren for the EuroSIDA Group.
AIDS. 2005 Apr 8;19(6):593-601 abstract
5 Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. A Alberti, N Clumeck, S Collins, W Gerlich, J Lundgren, G Palù, P Reiss, R Thiebaut, O Weiland, Y Yazdanpanah, S Zeuzem (The ECC Jury).
J Hepatol. 2005 May;42(5):615-24 abstract
6 Decline in oesophageal candidiasis and use of antimycotics in patients with HIV. A Mocroft, C Oancea, J van Lunzen, P Vanhems, D Banhegyi, A Chiesi, E Vinogradova, S Maayan, AN Phillips and J Lundgren.
Am J Gastroenterol. 2005 Jul;100(7):1446-54. abstract
7 Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal menigitis. CT Brandt, JD Lundgren, N Frimodt-Møller, T Christensen, T Benfield, F Espersen, DM Hougaard, C Østergaard.
J Neuroimmunol. 2005 Sep;166(1-2):126-31 abstract
8 Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection. A Mocroft, AN. Phillips, V Soriano, J Rockstroh, A Blaxhult, C Katlama, A Boron-Kaczmarska, L Viksna, O Kirk, JD Lundgren
AIDS Res Hum Retroviruses. Sep 2005, Vol. 21, No. 9: 743-752 abstract
9 Impact of Coinfection With HIV-1 and GB Virus C in Patients Receiving a Ritonavir-Boosted HAART Regimen: A Substudy to the MaxCmin1 Trial. HL Tillmann, T Kaiser, Z Fox, S Staszewski, F Antunes, AD Monforte, P Vernazza, A Hill, UB Dragsted, JD Lundgren; on behalf of the MaxCmin1 Trial Group.
J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):378-380 abstract
10 Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression. TB Kristiansen, AG Pedersen, J Eugen-Olsen, TL Katzenstein and JD Lundgren.
Scand J Infect Dis 2005; 37:890-901 abstract
11 Influence of Hepatitis C on HIV Disease Progression and Response to Antiretroviral Therapy. J Rockstroh, A Mocroft, V Soriano, C Tural, M Losso, A Horban, O Kirk, A Phillips, B Ledergerber, J Lundgren for the EuroSIDA study group.
J Infect Dis. 2005 Sep 15;192(6):992-1002 abstract
12 Is there evidence for an increase in the death-rate from liver-related disease in patients with HIV? A Mocroft, V Soriano, J Rockstroh, P Reiss, O Kirk, S de Wit, J Gatell, B Clotet, AN Phillips, JD Lundgren for the EuroSIDA study group.
AIDS. 2005 Dec 2; 19(18):2117-2125 abstract
13 Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?. A Mocroft, J Rockstroh, V Soriano, B Ledergerber, O Kirk, E Vinogradova, P Reiss, C Katlama, AN Phillips, JD Lundgren for the EuroSIDA study group.
Antivir. Ther. 2005;10(7):779-90 abstract
14 Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy. A Cozzi-Lepri, L Ruiz, C Loveday, AN Phillips, B Clotet, P Reiss, B Ledergerber, C Holkman Olsen, S Staszewski and JD Lundgren for the EuroSIDA Study Group.
Antivir Ther. 2005;10(7):791-802. abstract
15 Predictors of hypertension and changes of blood pressure in HIV-infected patients. R Thiebaut, WM El-Sadr, N Friis-Moller, M Rickenbach, P Reiss, AD Monforte, L Morfeldt, E Fontas, O Kirk, S De Wit, G Calvo, MG Law, F Dabis, CA Sabin, JD Lundgren; Data Collection of Adverse events of anti-HIV Drugs Study Group.
Antivir Ther. 2005;10(7):811-23 abstract
16 Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. E Girardi, CA Sabin, A d'Arminio Monforte, B Hogg, AN Phillips, MJ Gill, F Dabis, P Reiss, O Kirk, E Bernasconi, S Grabar, A Justice, S Staszewski, G Fatkenheuer, JA Sterne; Antiretroviral Therapy Cohort Collaboration.
Clin Infect Dis. 2005 Dec 15;41(12):1772-82. abstract
17 A randomised trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1 infected subjects. The MaxCmin2 trial. UB Dragsted, J Gerstoft, M Youle, Z Fox, M Losso, J Benetucci, DT Jayawwera, A Rieger, JN Bruun, A Castagna, B Gazzard, S Walmsley, A Hill, and JD Lundgren for the MaxCmin2 trial group.
Antivir Ther. 2005;10(6):735-43. abstract
18 The ART Cohort Collaboration: AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others? Writing committee: Sabin, CA, Hogg B, Dabis F, Gill MJ, Phillips AN, Reiss P, Fätkenheuer G, Grabar S, Lundgren J, Justice A, Ledergerber B, d'Arminio Monforte A, Staszewski A and Sterne JAC. AIDS 2005 19: 1995-2000.
19 Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. Margaret May, Kholoud Porter, Jonathan A. C. Sterne, Patrick Royston, Matthias Egger, ART-CC (The Antiretroviral Therapy Cohort Collaboration) and CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe). Journal of Clinical Epidemiology 2005 58: 1033-1041.
20 The ART Cohort Collaboration: The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Writing committee: D'Arminio MA, Sabin CA, Phillips A, Sterne JAC, May M, Justice AC, Dabis F, Grabar C, Ledergerber B, Gill J, Reiss P and Egger M. Archives of Internal Medicine 2005 165: 416-23
Updated: 16 Sep 2009